Testing effectiveness (Phase 2)Study completedNCT01392989
What this trial is testing
Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders
Who this might be right for
Neural Tube DefectsAnemiaLeukemia, Myeloid+3 more
Everett Meyer 44